Development and biophysical characterization of a humanized FSH-blocking monoclonal antibody therapeutic formulated at an ultra-high concentration
- Icahn School of Medicine at Mount Sinai, United States
- Population Council, United States
- Maine Medical Center Research Institute, United States
Peer review process
This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.
History
- Version of Record published
- Accepted Manuscript published
- Accepted
- Preprint posted
- Received
